190 related articles for article (PubMed ID: 17420283)
1. Selective tissue distribution of tibolone metabolites in mature ovariectomized female cynomolgus monkeys after multiple doses of tibolone.
Verheul HA; van Iersel ML; Delbressine LP; Kloosterboer HJ
Drug Metab Dispos; 2007 Jul; 35(7):1105-11. PubMed ID: 17420283
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic parameters of tibolone and metabolites in plasma, urine, feces, and bile from ovariectomized cynomolgus monkeys after a single dose or multiple doses of tibolone.
Verheul HA; Timmer CJ; van Iersel ML; Delbressine LP; Kloosterboer HJ
Drug Metab Dispos; 2007 Jul; 35(7):1112-8. PubMed ID: 17420282
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
Kloosterboer HJ; Löfgren L; von Schoulz E; von Schoultz B; Verheul HA
Reprod Sci; 2007 Feb; 14(2):151-9. PubMed ID: 17636226
[TBL] [Abstract][Full Text] [Related]
4. Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
Verheul HA; Blok LJ; Burger CW; Hanifi-Moghaddam P; Kloosterboer HJ
Reprod Sci; 2007 Feb; 14(2):160-8. PubMed ID: 17636227
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic parameters of sulfated tibolone metabolites in postmenopausal women after single and multiple doses of tibolone.
Verheul HA; Timmer CJ; Kloosterboer HJ
Clin Pharmacol Ther; 2007 Apr; 81(4):573-9. PubMed ID: 17301737
[TBL] [Abstract][Full Text] [Related]
6. Tissue-selectivity: the mechanism of action of tibolone.
Kloosterboer HJ
Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of tibolone and its metabolites in uterine and vaginal tissue of rat and human origin.
Blom MJ; Wassink MG; De Gooyer ME; Ederveen AG; Kloosterboer HJ; Lange J; Lambert JG; Goos HJ
J Steroid Biochem Mol Biol; 2006 Sep; 101(1):42-9. PubMed ID: 16893645
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
9. Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs).
Wang M; Ebmeier CC; Olin JR; Anderson RJ
Steroids; 2006 May; 71(5):343-51. PubMed ID: 16360722
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence studies of tibolone in premenopausal women and effects on expression of the tibolone-metabolizing enzyme AKR1C (aldo-keto reductase) family caused by estradiol.
Kang KW; Kim YG
J Clin Pharmacol; 2008 Dec; 48(12):1430-7. PubMed ID: 18832293
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant effect of the active metabolites of tibolone.
Stark J; Varbiro S; Sipos M; Tulassay Z; Sara L; Adler I; Dinya E; Magyar Z; Szekacs B; Marczell I; Kloosterboer HJ; Racz K; Bekesi G
Gynecol Endocrinol; 2015 Jan; 31(1):31-5. PubMed ID: 25054375
[TBL] [Abstract][Full Text] [Related]
12. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Mahony MC; Archer DF
Menopause; 2004; 11(1):82-8. PubMed ID: 14716187
[TBL] [Abstract][Full Text] [Related]
13. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
14. Conversion of tibolone to 7alpha-methyl-ethinyl estradiol using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry: interpretation and clinical implications.
Zacharia LC; Jackson EK; Kloosterboer HJ; Imthurn B; Dubey RK
Menopause; 2006; 13(6):926-34. PubMed ID: 17006378
[TBL] [Abstract][Full Text] [Related]
15. Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid.
Steckelbroeck S; Jin Y; Oyesanmi B; Kloosterboer HJ; Penning TM
Mol Pharmacol; 2004 Dec; 66(6):1702-11. PubMed ID: 15383625
[TBL] [Abstract][Full Text] [Related]
16. Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases.
Falany JL; Macrina N; Falany CN
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):383-91. PubMed ID: 15145448
[TBL] [Abstract][Full Text] [Related]
17. Multisystem evaluations of the long-term effects of tibolone on postmenopausal monkeys.
Clarkson TB; Anthony MS; Cline JM; Lees CJ; Ederveen AG
Maturitas; 2004 Aug; 48 Suppl 1():S24-9. PubMed ID: 15337245
[TBL] [Abstract][Full Text] [Related]
18. 7alpha-Methyl-ethinyl estradiol is not a metabolite of tibolone but a chemical stress artifact.
Dröge MJ; Oostebring F; Oosting E; Verheul HA; Kloosterboer HJ
Menopause; 2007; 14(3 Pt 1):474-80. PubMed ID: 17237734
[TBL] [Abstract][Full Text] [Related]
19. Effect of a standardized meal on the bioavailability of a single oral dose of tibolone 2.5 mg in healthy postmenopausal women.
Timmer CJ; Huisman JA
Pharmacotherapy; 2002 Mar; 22(3):310-5. PubMed ID: 11899948
[TBL] [Abstract][Full Text] [Related]
20. Tissue-selective effects of tibolone on the breast.
Kloosterboer HJ
Maturitas; 2004 Sep; 49(1):S5-S15. PubMed ID: 15351102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
